Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice
Abstract The anti-bone resorptive drugs denosumab, an anti-human-RANKL antibody, and zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, have recently been applied for treatment of pediatric patients with bone diseases, though details regarding their effects in growing children have yet to...
Guardado en:
Autores principales: | Motoki Isawa, Akiko Karakawa, Nobuhiro Sakai, Saki Nishina, Miku Kuritani, Masahiro Chatani, Takako Negishi-Koga, Masashi Sato, Mitsuko Inoue, Yukie Shimada, Masamichi Takami |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b70533e1eb9249e487693f5b7a41ef4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression
por: Ayumi Shoji-Matsunaga, et al.
Publicado: (2017) -
Application of cryopreservation to tooth germ transplantation for root development and tooth eruption
por: Xinghan Li, et al.
Publicado: (2021) -
Effects of a single intravaneous dose of zoledronic acid on bone healing following tooth extraction in ovariectomized rabbits
por: Esra Mavi, et al.
Publicado: (2021) -
The effect of high concentration of zoledronic acid on tooth induced movement and its repercussion on root, periodontal ligament and alveolar bone tissues in rats
por: Fátima Regina Nunes de Sousa, et al.
Publicado: (2021) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011)